Cargando…
Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma
BACKGROUND: The response of advanced clear cell renal cell carcinoma (ccRCC) to immunotherapy is still not durable, suggesting that the immune landscape of ccRCC still needs to be refined, especially as some molecules that have synergistic effects with immune checkpoint genes need to be explored. ME...
Autores principales: | Zhang, Zhi-Cheng, Liu, Yi-Fu, Xi, Ping, Nie, Ye-Chen, Sun, Ting, Gong, Bin-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837903/ https://www.ncbi.nlm.nih.gov/pubmed/36635779 http://dx.doi.org/10.1186/s41065-023-00262-3 |
Ejemplares similares
-
Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms
por: Xiao, Yusha, et al.
Publicado: (2019) -
Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway: CENPM promotes lung adenocarcinoma progression
por: Liu, Chao, et al.
Publicado: (2021) -
Upregulation of CENPM facilitates tumor metastasis via the mTOR/p70S6K signaling pathway in pancreatic cancer
por: Zheng, Chenlei, et al.
Publicado: (2020) -
Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis
por: Cui, Yuanshan, et al.
Publicado: (2021) -
Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)